Welcome visitor Log In - or - Register
0 items /
View Cart
Check Out
four ways
Quick Search:
A tyrosine kinase inhibitor (TKI) specifically targeting Bcr-Abl— the definitive causative abnormality in CML—and its mutant forms, and is significantly more selective and potent inhibitor of Bcr-Abl than imatinib.
Catalog NO: CT-NL001
Synonym: Tasigna
CAS NO: 641571-10-0
Mol. Formula: C28H22F3N7O
MW: 529.5
** in vivo Quality material. >99.5% purity by HPLC. Anhydrous, validated by a spot-on quantitative elemental analysis. Bulk, prompt.